1. Home
  2. NKGN vs NCRA Comparison

NKGN vs NCRA Comparison

Compare NKGN & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • NCRA
  • Stock Information
  • Founded
  • NKGN 2017
  • NCRA 2002
  • Country
  • NKGN United States
  • NCRA Taiwan
  • Employees
  • NKGN N/A
  • NCRA N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • NCRA Farming/Seeds/Milling
  • Sector
  • NKGN Health Care
  • NCRA Consumer Staples
  • Exchange
  • NKGN Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • NKGN 14.1M
  • NCRA 15.4M
  • IPO Year
  • NKGN N/A
  • NCRA N/A
  • Fundamental
  • Price
  • NKGN $0.29
  • NCRA $1.14
  • Analyst Decision
  • NKGN
  • NCRA
  • Analyst Count
  • NKGN 0
  • NCRA 0
  • Target Price
  • NKGN N/A
  • NCRA N/A
  • AVG Volume (30 Days)
  • NKGN 473.5K
  • NCRA 5.7K
  • Earning Date
  • NKGN 11-12-2024
  • NCRA 08-14-2024
  • Dividend Yield
  • NKGN N/A
  • NCRA N/A
  • EPS Growth
  • NKGN N/A
  • NCRA N/A
  • EPS
  • NKGN N/A
  • NCRA N/A
  • Revenue
  • NKGN N/A
  • NCRA $26,403,874.00
  • Revenue This Year
  • NKGN N/A
  • NCRA N/A
  • Revenue Next Year
  • NKGN N/A
  • NCRA N/A
  • P/E Ratio
  • NKGN N/A
  • NCRA N/A
  • Revenue Growth
  • NKGN N/A
  • NCRA 33.73
  • 52 Week Low
  • NKGN $0.29
  • NCRA $0.73
  • 52 Week High
  • NKGN $5.10
  • NCRA $1.60
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 24.16
  • NCRA 59.29
  • Support Level
  • NKGN $0.36
  • NCRA $1.06
  • Resistance Level
  • NKGN $0.44
  • NCRA $1.10
  • Average True Range (ATR)
  • NKGN 0.04
  • NCRA 0.10
  • MACD
  • NKGN 0.00
  • NCRA 0.01
  • Stochastic Oscillator
  • NKGN 1.18
  • NCRA 74.29

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: